Skip to main content
SpringerLink
Log in

Prostatic Cancer: Advances in Diagnosis

  • Chapter
Cancer of the Prostate and Kidney

Part of the book series: NATO Advanced Science Institutes Series ((NSSA,volume 53))

  • 63 Accesses

Abstract

Prostatic cancer constitutes one of the most commonly diagnosed cancers in older males (1). The accumulated information concerning this disease is enormous but we are still unable to diagnose the disease in the early stages, to assess the extent of disease in a non invasive way or to select treatment according to the lethal potential of the tumor. This paper brings data together that have or seem to have value in establishing answers to these three questions. Any of these problems, if answered, would represent a true advance in diagnosis. Physical examination, histological confirmation by biopsy, medical imaging techniques and prostatic tumor markers have been selected for presentation.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 54.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. C. Bouffioux, Le Cancer de la Prostate, Acta Urol. Belg. 47:190 (1979).

    Google Scholar 

  2. H.J. Jewett, Significance of the palpable prostatic nodule, JAMA 160:838 (1956).

    Article  CAS  Google Scholar 

  3. G. Guinan, I. Bush, V. Ray, R. Vieth, R. Rao, and R. Bhatti, The accuracy of the rectal examination in the diagnosis of prostate carcinoma, New. Engl. J. Med. 303:499 (1980).

    Article  PubMed  CAS  Google Scholar 

  4. W.J. Catalona, Yield from routine prostatic needle biopsy in patients more than 50 years old referred for urologic evaluations: A preliminary report, J. Urol. 124:844 (1980).

    PubMed  CAS  Google Scholar 

  5. D.P. Byar, F.K. Mostofi, and VACURG, Carcinoma of the prostate. Prognostic evaluation of certain pathological features in 208 radical prostatectomies, Cancer 30:5 (1972).

    Article  PubMed  CAS  Google Scholar 

  6. M.R.G. Robinson, Personal Communication.

    Google Scholar 

  7. P.B. Hudson, A.L. Finkle, A.J. Hopkens, E.E. Sproul, and A.P. Stout, Prostatic cancer XI early prostatic cancer diagnosed by arbitrary open perineal biopsy among 300 unselected patients, Cancer 7:690 (1954).

    Article  PubMed  CAS  Google Scholar 

  8. D.P. Byar and VACURG, Survival of patients with incidentally found microscopic cancer of the prostate. Results of a clinical trial of conservative treatment, J. Urol. 108:908 (1972).

    PubMed  CAS  Google Scholar 

  9. A.C. Broders, Grading of Carcinoma, Minnesota Med. 8:726 (1925).

    Google Scholar 

  10. F.K. Mostofi, Problems of grading carcinoma of the prostate, Semin. Oncol. 3:161 (1976).

    PubMed  CAS  Google Scholar 

  11. D.F. Gleason, G.T. Mellinger, and VACURG, Prediction of prognosis for prostatic adenocarcinoma by combined histologic grading and clinical staging, J. Urol. 111:58 (1974).

    PubMed  CAS  Google Scholar 

  12. D.F. Paulson, P.V. Piserchia, and W. Gardner, Predictors of lymphatic spread in prostatic adeno-carcinoma. Uro-oncology Research Group study, J. Urol. 123:697 (1980).

    PubMed  CAS  Google Scholar 

  13. J.F. Gaeta, J.E. Asurwatham, G. Miller, and G.P. Murphy, Histologic grading of primary prostatic cancer. A new approach to an old problem, J. Urol. 123:689 (1980).

    PubMed  CAS  Google Scholar 

  14. L. Denis, Clinical cancer of prostate. Influence of tumor stage and grade on five year survival, Acta Urol. Belg. 40:126 (1972).

    PubMed  CAS  Google Scholar 

  15. P.J.B. Carstens, Perineural glands in normal and hyperplastic prostates, J. Urol. 123:686 (1980).

    PubMed  CAS  Google Scholar 

  16. N. O’Donoghue and R. Pugh, Early diagnosis of prostatic carcinoma: the role of trans-urethral resection, Brit. J. Urol. 116:759 (1976).

    Google Scholar 

  17. W.J. Catalona and M. Menon, New screening and diagnostic tests for prostate cancer and immunologie assessment, Suppl. to Urology 17:61 (1981).

    CAS  Google Scholar 

  18. J.M. Barry, A. Goldstein, and M. Hubbard, Human leucocyte A and B antigens in patients with prostatic adenocarcinoma, J. Urol. 124:847 (1980).

    PubMed  CAS  Google Scholar 

  19. G.R. Prout Jr., P. Griffin, J.J. Daly, and W.U. Shipley, Nodal involvement as prognostic indicator in prostatic carcinoma, Suppl, to Urology 17:72 (1981).

    Google Scholar 

  20. C.B. Brendler, L.K. Cleeve, E. Anderson, and D.F. Paulson, Staging pelvic lymphadenectomy for carcinoma of the prostate: risk versus benefit, J. Urol. 124:849 (1980).

    PubMed  CAS  Google Scholar 

  21. L. Denis, L. Appel, J. Broos, and G. Declercq, Evaluation of prostatic cancer by transrectal ultrasonography and CT scan, Acta Urol. Belg. 48:71 (1980).

    PubMed  CAS  Google Scholar 

  22. M.I. Resnick, Non invasive techniques in evaluating patients with carcinoma of the prostate, Suppl. to Urology, 17:25 (1981).

    CAS  Google Scholar 

  23. J. Pradel, J.M. Duclos, M. Charton, and J.M. Brussel, La tomodensitometrie dans le bilan d’extension des cancers prostatiques, in: “Sem. D’Uro-Nephrologie,” R. Kuss and M. Legrain, eds., Masson, Paris (1981), p.31.

    Google Scholar 

  24. G. Declercq, L. Denis, J. Broos, and L. Appel, Evaluation of lower urinary tract by computed tomography and transrectal ultrasonography, Comp. Tom. In Press.

    Google Scholar 

  25. H. Watanabe, S.H. Holmes, H.J. Holm, and B.B. Goldberg, “Diagnostic Ultrasound in Urology and Nephrology,” Ingaku Shion Ltd., Tokyo (1981).

    Google Scholar 

  26. H.H. Holm and J. Gammelgaard, Ultrasonically guided precise needle placement in the prostate and the seminal vesicles, J. Urol. 125:385 (1981).

    PubMed  CAS  Google Scholar 

  27. H. Watanabe, T. Mishina, and H. Ohe, Mass screening of prostatic diseases, in: “Prostatic Carcinoma and Biology and Diagnosis,” E.S.E. Hafez and E. Spring Mills, Martinus Nyhoff, The Hague (1981), p.71.

    Chapter  Google Scholar 

  28. E.B. Gutman, E.E. Sproul, and A.B. Gutman, Increased phosphatase activity of bone at site of osteoplastic metastases secondary to carcinoma of prostate gland, Am. J. Cancer 28:485 (1936).

    CAS  Google Scholar 

  29. A.V. Roy, M.E. Brouwer, and J.E. Hayden, Sodium thymolphthalein monophosphate: a new acid phosphatase substrate with greater specificity for the prostate in serum, Clin. Chem. 17:1093 (1971).

    PubMed  CAS  Google Scholar 

  30. C.Y. Li, R.A. Chuda, W.K.W. Lam, and L.T. Yam, Acid phosphatases in human plasma, J. Lab. Clin. Med. 82:446 (1973).

    PubMed  CAS  Google Scholar 

  31. W.H. Fishman and F. Lerner, A method for estimating serum acid phosphatase of prostatic origin, J. Biol. Chem. 200:89 (1953).

    PubMed  CAS  Google Scholar 

  32. J.F. Cooper and A.G. Foti, A radioimmunoassay for prostatic acid phosphatase. I. Methodology and range of normal male serum values, Invest. Urol. 12:98 (1974).

    CAS  Google Scholar 

  33. J.F. Cooper and A.G. Foti, A radioimmunoassay for prostatic acid phosphatase, Nat. Can. Inst. Monograph 49:235 (1978).

    CAS  Google Scholar 

  34. J.F. Cooper, A.G. Foti, and P.W. Shank, Radioimmunochemical measurement of bone marrow prostatic acid phosphatase, J. Urol. 119:388 (1978).

    PubMed  CAS  Google Scholar 

  35. P. Vihko, E. Sajanti, O. Jänne, L. Peltonen, and R. Vihko, Serum prostate-specific acid phosphatase: development and validation of a specific radioimmunoassay, Clin. Chem. 24:1915 (1978).

    PubMed  CAS  Google Scholar 

  36. T.M. Chu, M.C. Wang, R. Kajdasz, E.A. Barnard, P. Kucil, and G.P. Murphy, Prostate-specific acid phosphohydrolase in the diagnosis of prostate cancer, Proc. Am. Assoc. Cancer Res. 17:191 (1976).

    Google Scholar 

  37. T.M. Chu, Serum acid phosphohydrolase (phosphatase) and ribonuclease in diagnosis of prostatic cancer, Antibiotics Chemotherapy 22:98 (1978).

    CAS  Google Scholar 

  38. C.L. Lee, M.C. Wang, G.P. Murphy, and T.M. Chu, A solid phase fluorescent immunoassay for human prostatic acid phosphatase, Cancer Res. 38:2871 (1978).

    PubMed  CAS  Google Scholar 

  39. C.L. Lee, C.S. Killian, G.P. Murphy, and T.M. Chu, A solid-phase immunoadsorbant assay for serum prostatic acid phosphatase, Clin. Chim. Acta 101:209 (1980).

    Article  PubMed  CAS  Google Scholar 

  40. R.S. Galen and S.R. Gambino,’Beyond Normality: The Predictive Value and Efficiency of Medical Diagnosis,” Wiley, New York (1975).

    Google Scholar 

  41. J.C Griffiths, Prostate-specific acid phosphatase: re-evaluation of radioimmunoassay in diagnosing prostatic disease, Clin. Chem. 26:433 (1980).

    PubMed  CAS  Google Scholar 

  42. A.G. Foti, J.F. Cooper, H. Herschman, and R.R. Malvaez, Detection of prostatic cancer by solid-phase radioimmunoassay of serum prostatic acid phosphatase, New Engl. J. Med. 297:1357 (1977).

    Article  PubMed  CAS  Google Scholar 

  43. D.M. Goldberg and G. Ellis, An assessment of serum acid and alkaline phosphatase determination in prostatic cancer with a clinical validation of an acid phosphatase assay utilizing adenosine 3′-monophosphatate as substrate, J. Clin. Pathol. 27:140 (1974).

    Article  PubMed  CAS  Google Scholar 

  44. A.W. Bruce, D.E. Mahan, A. Morales, A.F. Clark, and W.D. Belville, An objective look at acid phosphatase determinations. A comparison of biochemical and immunological methods, Brit. J. Urol 51:213 (1979).

    Article  PubMed  CAS  Google Scholar 

  45. A. Wajsman, T.M. Chu, J. Saroff, N. Slack, and G.P. Murphy, Two new, direct and specific methods of acid phosphatase determination, National field Trial. Urology 13:8 (1979).

    Article  PubMed  CAS  Google Scholar 

  46. D.E. Mahan and B.P. Doctor, A radioimmune assay for human prostatic acid phosphatase-levels in prostatic disease, Clin. Biochem. 12:10 (1979).

    Article  PubMed  CAS  Google Scholar 

  47. A.W. Bruce, D.E. Mahan, L.D. Sullivan, and L. Goldenberg, The significance of prostatic acid phosphatase in adenocarcinoma of the prostate, J. Urol. 125:357 (1981).

    PubMed  CAS  Google Scholar 

  48. G.R. Quinones, T.J. Rohnef, J.R. Drago, and L.M. Demers, Will prostatic acid phosphatase determination by radioimmunoassay increase the diagnosis of early prostatic cancer? J. Urol. 125:361 (1981).

    PubMed  CAS  Google Scholar 

  49. M.H. Zweig, A.C. Steirteghem, and A.N. Schechter, Radioimmunoassay of creatine kinase isoenzymes in human serum, Isoenzyme BB, Clin. Chem. 24:422 (1978).

    PubMed  CAS  Google Scholar 

  50. P.D. Feld and D.L. Witte, Presence of creatine kinase BB iso-enzymes in some patients with prostatic carcinoma, Clin. Chem. 23:1930 (1977).

    PubMed  CAS  Google Scholar 

  51. R.D. Feld, A.C. Van Steirteghem, M. H. Zweig, G.W. Weimar, A.S. Narayana, and D.L. Witte, The presence of creatine kinase BB isoenzyme in patients with prostatic cancer, Clin. Chim. Acta 100:267 (1980).

    Article  PubMed  CAS  Google Scholar 

  52. L.M. Silverman, G.B. Demer, M.H. Zweig, A.C. Van Steirteghem, and Z.A. Tökés, Creatine kinase BB: a new tumor associated marker, Clin. Chem. 25:1432 (1979).

    PubMed  CAS  Google Scholar 

  53. M.H. Zweig and A.C. Van Steirteghem, Serum creatine kinase BB (RIA) as a tumor marker: Studies in various cancers and a comparison to prostatic acid phosphatase, J. Nat. Canc. Inst. In Press.

    Google Scholar 

  54. R.Y. Kirdani, J.P. Karr, G.P. Murphy, and A.A. Sandberg, Clinical markers in prostatic cancer, in: “Prostatic Carcinoma — Biology and Diagnosis,” E.S.E. Hafez and Spring — Mills, eds, Martinus Nyhoff, The Hague (1981), p.79.

    Chapter  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Academic Hospital, Free University of Brussels, A.Z. Middelheim (Antwerp), Belgium

    L. Denis & A. Van Steirteghem

Authors
  1. L. Denis
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Van Steirteghem
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. University of Palermo, Palermo, Italy

    M. Pavone-Macaluso

  2. St. James’s University Hospital, Leeds, England

    P. H. Smith

Rights and permissions

Reprints and permissions

Copyright information

© 1983 Springer Science+Business Media New York

About this chapter

Cite this chapter

Denis, L., Van Steirteghem, A. (1983). Prostatic Cancer: Advances in Diagnosis. In: Pavone-Macaluso, M., Smith, P.H. (eds) Cancer of the Prostate and Kidney. NATO Advanced Science Institutes Series, vol 53. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-4349-3_20

Download citation

  • DOI: https://doi.org/10.1007/978-1-4684-4349-3_20

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-1-4684-4351-6

  • Online ISBN: 978-1-4684-4349-3

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation